Browsing by Author Mehta, Hemal

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2016Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema: a reviewFraser-Bell, Samantha; Gillies, Mark; Mehta, Hemal; Central Clinical School: Ophthalmology & Eye Health; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema: a review, Clinical and Experimental Ophthalmology, vol.44, 4, 2016,pp 335-339
2016Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: Data from the BEVORDEX randomised clinical trialCampain, Anna; Fraser-Bell, Samantha; Gillies, Mark; Mehta, Hemal; Quin, Godfrey; Yeung, Aaron; Keane, Pearse A; Lim, Lyndell; McAllister, Ian L; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Ophthalmology & Eye Health; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: Data from the BEVORDEX randomised clinical trial, British Journal of Ophthalmology, vol.100, 7, 2016,pp 1000-1004
2016Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: Data from the BEVORDEX randomised clinical trialCampain, Anna; Fraser-Bell, Samantha; Gillies, Mark; Mehta, Hemal; Quin, Godfrey; Yeung, Aaron; Keane, Pearse A; Lim, Lyndell; McAllister, Ian L; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Ophthalmology & Eye Health; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: Data from the BEVORDEX randomised clinical trial, British Journal of Ophthalmology, vol.100, 7, 2016,pp 1000-1004
2016Metaanalysis of real-world outcomes of intravitreal ranibizumab for the treatment of neovascular age-related macular degenerationBarthelmes, Daniel; Gillies, Mark; Kim, Leah; Mehta, Hemal; Nguyen, Vuong; Central Clinical School: Ophthalmology & Eye Health; Central Clinical School: Save Sight & Eye Health Inst.; Medicine; Central Clinical School: Save Sight & Eye Health Inst.; Biological SciencesMetaanalysis of real-world outcomes of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration, Retina: the Journal of Retinal and Vitreous Diseases, vol.36, 8, 2016,pp 1418-1431
2015Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedemaFraser-Bell, Samantha; Gillies, Mark; Mehta, Hemal; Central Clinical School: Ophthalmology & Eye Health; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema, Therapeutic Advances in Chronic Diseases, vol.6, 5, 2015,pp 234-245
2017Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedemaFraser-Bell, Samantha; Gillies, Mark; Mehta, Hemal; Alessandrello, Elizabeth; Lim, Lyndell; Wickremasinghe, Sanjeewa S; Central Clinical School: Ophthalmology & Eye Health; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema, British Journal of Ophthalmology, vol.101, 10, 2017,pp 1329-1333
2018Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedemaFraser-Bell, Samantha; Gillies, Mark; Mehta, Hemal; Nguyen, Vuong; Lim, Lyndell; Central Clinical School: Ophthalmology & Eye Health; Save Sight Institute; Save Sight Institute; Save Sight InstituteShort-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema, British Journal of Ophthalmology, vol.102, 4, 2018,pp 479-482